NEXENTIS TECHNOLOGIES INC. Convertible Debt, Current
NEXENTIS TECHNOLOGIES INC. (NXTS) had Convertible Debt, Current of $89.59 thousand as of 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2022-03-31
- 2021-03-31: Convertible Debt, Current $89.59K.
- 2020-12-31: Convertible Debt, Current $56.25K.
- 2020-09-30: Convertible Debt, Current $31.25K.
| Period end | Convertible Debt, Current |
|---|---|
| 2021-03-31 | $89.59K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $56.25K 10-K · filed 2022-03-31 |
| 2020-09-30 | $31.25K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |